TAT 2013

-

TAT, a leading oncology phase 1 meeting

TAT 2013, Paris, March 4-6 , 2013, will be the next meeting in the unique series "International Congress on Targeted Anticancer Therapies" (TAT), which is devoted to the most promising new molecularly-targeted cancer therapeutics. TAT meetings are leading oncology phase 1 meetings in Europe and a must-attend for clinical investigators, research scientists and drug development professionals in pharma, biotech and CROs:

• Focus on promising new agents and molecular targets that are - or soon will be - in phase 1 clinical study
• Clinical and translational research discussed extensively
• Educational introductions of target biology help "newcomers" understand the science behind new targets
• Excellent opportunities for young investigators to present for the first time in their career in a comfortable and overseeable setting
• Many of the world's leading phase 1 groups represented


Location:
Marriott Rive Gauche Hotel & Conference Center
France


Organizer: Congress by Design

4 Mar 2013

Upcoming Featured Events
1 Next 
63rd ASMS Conference5 Jun 2016
HPLC 201619 Jun 2016
AACC (American Association for Clinical Chemistry)31 Jul 2016
ASHG 201618 Oct 2016
Neuroscience 201612 Nov 2016



Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement